Trial intelligence / Profile preview

Esomeprazole for GERD-like symptoms in NSAID users

jRCT1091220218Completed

Sponsor
Chiba University
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Chiba University. Primary endpoint: FSSG scale total score. Started Jul 2015; status: completed.

02

Drugs

esomeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on jRCT1091220218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call